Paillère-Martinot M - Search Results

1

Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia.

Paillère-Martinot M, Caclin A, Artiges E, Poline JB, Joliot M, Mallet L, Recasens C, Attar-Lévy D, Martinot JL. Paillère-Martinot M, et al. Schizophr Res. 2001 May 30;50(1-2):19-26. doi: 10.1016/s0920-9964(00)00137-7. Schizophr Res. 2001. PMID: 11378311

2

[Central dopaminergic receptors and negative symptoms in schizophrenia].

Martinot JL, Paillere-Martinot ML, Loc'h C, Aubin F, Dao-Castellana MH, Deslauriers AG, Syrota A, Lecrubier Y. Martinot JL, et al. Ann Med Psychol (Paris). 1992 Feb-Mar;150(2-3):127-30. Ann Med Psychol (Paris). 1992. PMID: 1343506 French. No abstract available.

3

In vivo assessment of dopaminergic variables in schizophrenia.

Martinot JL, Paillere-Martinot ML, Lecrubier Y, Dao-Castellana MH, Loc'h C, Poirier MF, Allilaire JF, Feline A, Manus A, Aubin F, et al. Martinot JL, et al. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:470A-471A. doi: 10.1097/00002826-199201001-00245. Clin Neuropharmacol. 1992. PMID: 1354053 No abstract available.

4

The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.

Martinot JL, Paillère-Martinot ML, Loc'h C, Hardy P, Poirier MF, Mazoyer B, Beaufils B, Mazière B, Allilaire JF, Syrota A. Martinot JL, et al. Br J Psychiatry. 1991 Mar;158:346-50. doi: 10.1192/bjp.158.3.346. Br J Psychiatry. 1991. PMID: 1827999

5

Improvement of some schizophrenic deficit symptoms with low doses of amisulpride.

Paillère-Martinot ML, Lecrubier Y, Martinot JL, Aubin F. Paillère-Martinot ML, et al. Am J Psychiatry. 1995 Jan;152(1):130-4. doi: 10.1176/ajp.152.1.130. Am J Psychiatry. 1995. PMID: 7802104 Clinical Trial.

6

Delusional misidentification: a clinical, neuropsychological and brain imaging case study.

Paillère-Martinot ML, Dao-Castellana MH, Masure MC, Pillon B, Martinot JL. Paillère-Martinot ML, et al. Psychopathology. 1994;27(3-5):200-10. doi: 10.1159/000284870. Psychopathology. 1994. PMID: 7846238

7

Central D2 receptors and negative symptoms of schizophrenia.

Martinot JL, Paillère-Martinot ML, Loc'h C, Lecrubier Y, Dao-Castellana MH, Aubin F, Allilaire JF, Mazoyer B, Mazière B, Syrota A. Martinot JL, et al. Br J Psychiatry. 1994 Jan;164(1):27-34. doi: 10.1192/bjp.164.1.27. Br J Psychiatry. 1994. PMID: 8137107

8

In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia.

Martinot JL, Paillère-Martinot ML, Poirier MF, Dao-Castellana MH, Loc'h C, Mazière B. Martinot JL, et al. Psychopharmacology (Berl). 1996 Mar;124(1-2):154-8. doi: 10.1007/BF02245616. Psychopharmacology (Berl). 1996. PMID: 8935811 Clinical Trial.

9

Presynaptic dopaminergic function in the striatum of schizophrenic patients.

Dao-Castellana MH, Paillère-Martinot ML, Hantraye P, Attar-Lévy D, Rémy P, Crouzel C, Artiges E, Féline A, Syrota A, Martinot JL. Dao-Castellana MH, et al. Schizophr Res. 1997 Feb 7;23(2):167-74. doi: 10.1016/S0920-9964(96)00102-8. Schizophr Res. 1997. PMID: 9061812

10

Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.

Trichard C, Paillère-Martinot ML, Attar-Levy D, Recassens C, Monnet F, Martinot JL. Trichard C, et al. Am J Psychiatry. 1998 Apr;155(4):505-8. doi: 10.1176/ajp.155.4.505. Am J Psychiatry. 1998. PMID: 9545996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters